| Title: | Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease |
| Journal: | Genome Medicine |
| Published: | 28 Jun 2018 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/29954452/ |
| DOI: | https://doi.org/10.1186/s13073-018-0556-z |
| URL: | https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-018-0556-z |
| Citations: | 53 (17 in last 2 years) as of 8 Aug 2024 |
Publication 8545
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundStudies have shown that low haemoglobin and anaemia are associated with poor cognition, and anaemia is known to be associated with Alzheimer's disease (AD), but the mechanism of this risk is unknown. Here, we first seek to confirm the association between cognition and anaemia and secondly, in order to further understand the mechanism of this association, to estimate the direction of causation using Mendelian randomisation.MethodsTwo independent cohorts were used in this analysis: AddNeuroMed, a longitudinal study of 738 subjects including AD and age-matched controls with blood cell measures, cognitive assessments and gene expression data from blood; and UK Biobank, a study of 502,649 healthy participants, aged 40-69 years with cognitive test measures and blood cell indices at baseline. General linear models were calculated using cognitive function as the outcome with correction for age, sex and education. In UK Biobank, SNPs with known blood cell measure associations were analysed with Mendelian randomisation to estimate direction of causality. In AddNeuroMed, gene expression data was used in pathway enrichment analysis to identify associations reflecting biological function.ResultsBoth sample sets evidence a reproducible association between cognitive performance and mean corpuscular haemoglobin (MCH), a measure of average mass of haemoglobin per red blood cell. Furthermore, in the AddNeuroMed cohort, where longitudinal samples were available, we showed a greater decline in red blood cell indices for AD patients when compared to controls (p values between 0.05 and 10−6). In the UK Biobank cohort, we found lower haemoglobin in participants with reduced cognitive function. There was a significant association for MCH and red blood cell distribution width (RDW, a measure of cell volume variability) compared to four cognitive function tests including reaction time and reasoning (p < 0.0001). Using Mendelian randomisation, we then showed a significant effect of MCH on the verbal-numeric and numeric traits, implying that anaemia has causative effect on cognitive performance.ConclusionsLower haemoglobin levels in blood are associated to poor cognitive function and AD. We have used UK Biobank SNP data to determine the relationship between cognitive testing and haemoglobin measures and suggest that haemoglobin level and therefore anaemia does have a primary causal impact on cognitive performance.</p>
4 Authors
- Laura M. Winchester
- John Powell
- Simon Lovestone
- Alejo J. Nevado-Holgado
1 Application
| Application ID | Title |
|---|---|
| 15181 | Alzheimer?s Disease and Immune Events |
Enabling scientific discoveries that improve human health